TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
39.86
-0.34 (-0.85%)
At close: Mar 28, 2025, 4:00 PM
39.78
-0.08 (-0.20%)
After-hours: Mar 28, 2025, 7:56 PM EDT
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $5.79 billion as of March 28, 2025. Its market cap has increased by 136.66% in one year.
Market Cap
5.79B
Enterprise Value
5.73B
1-Year Change
136.66%
Ranking
Category
Stock Price
$39.86
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $5.79B, an increase of 63,512.61%. That is a compound annual growth rate of 54.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2025 | 6.31B | 34.76% |
Dec 31, 2024 | 4.69B | 81.18% |
Dec 29, 2023 | 2.59B | 50.41% |
Dec 30, 2022 | 1.72B | -36.69% |
Dec 31, 2021 | 2.72B | -60.29% |
Dec 31, 2020 | 6.84B | 518.96% |
Dec 31, 2019 | 1.11B | 225.13% |
Dec 31, 2018 | 339.90M | -41.33% |
Dec 29, 2017 | 579.30M | 127.62% |
Dec 30, 2016 | 254.50M | -59.38% |
Dec 31, 2015 | 626.60M | -10.02% |
Dec 31, 2014 | 696.40M | 433.23% |
Dec 31, 2013 | 130.60M | 43.20% |
Dec 31, 2012 | 91.20M | 91,100.00% |
Dec 30, 2011 | 100.00K | -97.92% |
Dec 31, 2010 | 4.80M | -47.25% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |